In this section
@article{Carhart-Harris:2013:10.1136/jnnp-2013-306103.17,
author = {Carhart-Harris, R},
doi = {10.1136/jnnp-2013-306103.17},
journal = {J Neurol Neurosurg Psychiatry},
title = {Psychedelic drugs, magical thinking and psychosis.},
url = {http://dx.doi.org/10.1136/jnnp-2013-306103.17},
volume = {84},
year = {2013}
}
TY - JOUR
AB - After completing an undergraduate degree in Psychology in 2003, Robin studied psychoanalysis at Masters level, receiving his MA in 2004. In 2005, Robin began a four year PhD in Psychopharmacology at the University of Bristol. Working for Professor David Nutt and Dr Sue Wilson, Robin's thesis focused on sleep and serotonin function in ecstasy users. Robin conducted a clinical study involving sleep electroencephalography (EEG) and tryptophan depletion. In 2009, working closely with the Beckley Foundation, he successfully coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years. Also in 2009, Robin moved to Imperial College London to continue his work under the supervision of Professor David Nutt. With the collaboration of Professor Richard Wise at Cardiff University, Robin has since coordinated the first resting state fMRI investigation of a classic psychedelic drug and the first fMRI and PET investigations of psilocybin and MDMA. Robin is first author on a number of publications in peer-reviewed scientific journals including review articles with eminent neuroscientists Professor's Helen Mayberg and Karl Friston. He has presented his data at several international conferences and has appeared on BBC News.
AU - Carhart-Harris,R
DO - 10.1136/jnnp-2013-306103.17
PY - 2013///
TI - Psychedelic drugs, magical thinking and psychosis.
T2 - J Neurol Neurosurg Psychiatry
UR - http://dx.doi.org/10.1136/jnnp-2013-306103.17
UR - http://www.ncbi.nlm.nih.gov/pubmed/23922414
VL - 84
ER -
